SOUTH
SAN FRANCISCO, Calif., May 1, 2024
/PRNewswire/ -- IDEAYA Biosciences, Inc. (NASDAQ: IDYA), a
precision medicine oncology company committed to the discovery and
development of targeted therapeutics, announced its participation
in an upcoming investor relations event.
RBC Capital Markets Global Healthcare Conference
Tuesday, May 14th, 2024 at
3:05 PM ET
- Fireside chat with Yujiro S. Hata, Chief Executive
Officer, hosted by Gregory Renza,
Director and Senior Biotechnology Research Analyst
A live audio webcast of the conference event, as permitted by
the conference host, will be available at the "Investors/Events"
section of the IDEAYA website at
https://ir.ideayabio.com/events and/or through the conference
host. A replay of available webcasts will be accessible for
30 days following the live event.
About IDEAYA Biosciences
IDEAYA is a precision medicine oncology company committed to the
discovery and development of targeted therapeutics for patient
populations selected using molecular diagnostics. IDEAYA's
approach integrates capabilities in identifying and validating
translational biomarkers with drug discovery to select patient
populations most likely to benefit from its targeted
therapies. IDEAYA is applying its early research and drug
discovery capabilities to synthetic lethality – which represents an
emerging class of precision medicine targets.
Forward-Looking Statements
This press release contains forward-looking statements,
including, but not limited to, statements related to participation
in and/or presentation at certain investor relations events. IDEAYA
undertakes no obligation to update or revise any forward-looking
statements. For a further description of the risks and
uncertainties that could cause actual results to differ from those
expressed in these forward-looking statements, as well as risks
relating to the business of IDEAYA in general, see IDEAYA's recent
Annual Report on Form 10-K filed on February
20, 2024 and any current and periodic reports filed with the
U.S. Securities and Exchange Commission.
Investor and Media Contact
IDEAYA Biosciences
Andres Ruiz Briseno
Senior Vice President, Head of Finance and Investor Relations
investor@ideayabio.com
View original content to download
multimedia:https://www.prnewswire.com/news-releases/ideaya-biosciences-to-participate-in-upcoming-may-2024-investor-relations-event-302130345.html
SOURCE IDEAYA Biosciences, Inc.